Amesite Inc. Unveils Pricing for Its Latest Public Offering
Amesite Inc, a pioneering technology firm specializing in AI-driven solutions, has announced the pricing details of its newest public offering. This offering includes the sale of 1,201,667 shares of common stock, priced at $3.00 per share, which is expected to raise around $3.6 million.
Participation from Company Leadership
Notably, several officers and directors within Amesite will be participating in this offering, contributing approximately $1.26 million in aggregate subscriptions. This indicates a strong belief in the company's future, as the leadership invests alongside public shareholders.
Closing Details of the Offering
The public offering is anticipated to close shortly, pending standard closing conditions, specifically on January 8, 2025. This rapid timeline reflects the company's readiness to take advantage of market opportunities and enhance its operational capabilities.
Use of Proceeds
The funding from this offering will be utilized strategically, earmarked for general corporate purposes, including capital expenditures, working capital, and administrative expenses. This plan demonstrates the company's commitment to sustainable growth and operational efficiency.
Engagement of Financial Partners
Laidlaw & Company (UK) Ltd. and Craft Capital Management LLC are facilitating this offering as joint book-running managers. Their expertise will be invaluable in ensuring that the offering successfully meets its targets.
About Amesite Inc.
Amesite Inc. is at the forefront of developing innovative technologies that cater to both business-to-consumer and business-to-business markets. By designing AI-driven solutions, Amesite strives to enhance user experience and efficiency in various sectors. One of their key products, NurseMagic™, caters specifically to health and care professionals, simplifying documentation and improving patient communication.
Understanding NurseMagic™
NurseMagic™ is designed to streamline the often complex tasks of creating nursing notes and managing patient interactions. The application not only helps in documentation but also offers personalized guidance, thus improving patient care standards and enhancing the workflow for nurses.
Investor Relations Contact
For more information, interested parties can reach out to MJ Clyburn at TraDigital IR via email at clyburn@tradigitalir.com. This will facilitate inquiries regarding the public offering or any other investor-related questions.
Frequently Asked Questions
What is the public offering price for Amesite's shares?
The public offering price for Amesite's shares is set at $3.00 per share.
How much is Amesite expected to raise from this offering?
Amesite anticipates raising approximately $3.6 million from this public offering.
Who are the financial partners managing the offering?
Laidlaw & Company (UK) Ltd. and Craft Capital Management LLC are acting as joint book-running managers for the offering.
When is the offering expected to close?
The offering is expected to close on January 8, 2025, subject to standard closing conditions.
What will the proceeds from the offering be used for?
The proceeds will be utilized for general corporate purposes, including capital expenditures, working capital, and administrative expenses.
